Wasawas, Venjelie .
HRN: 22-96-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2023
CEFTAZIDIME 1GM (VIAL)
04/30/2023
05/06/2023
IVTT
140mg
Q8
AGE With Moderate Dehydration, Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes